Stock screener

ORKA

Conviction 90HealthcareScan · Mon, Aug 10, 2026
ORKA$105.20+6.46%
ResistanceSupportVol 14Insider sell
63 bars
4
4
2
3
4
3
Vol MA14 772.56K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Oruka Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.orukatx.com
Price105.20
Change+6.46%
Gap-0.06%
Rel volume1.50×
Avg volume891.6K
Avg $ vol83.49M
SMA 2093.41
SMA 5082.71
SMA 20051.16
Price vs 50+27.19%
Price vs 200+105.64%
MA stackbullish
50/200 cross
Supertrendup · 85.52
RSI (14)70
MACD hist0.44
MACD crossbull · 4d
Stoch %K / %D100 / 93
ADX (14)29
+DI / −DI28 / 12
RSI divergence
MACD divergence
ATR %+5.02%
ADR %5.54%
52w high105.20
52w low13.05
From 52w high+0.00%
Above 52w low+706.13%
New 52w highYes
SqueezeOff
Bollinger width21.54%
%B1.09
Donchian pos99.90%
Donchian high105.23
Donchian low80.72
AVWAP (52w high)102.65
vs AVWAP high+2.49%
AVWAP (52w low)58.12
vs AVWAP low+81.02%
OBV trendFlat
Chaikin MF (20)0.30
Today vs 20d1.50×
Avg vol (14d)772.56K
Avg vol (20d)891.6K
Avg $ vol (20d)83.49M
Market cap6.97B
RS 3m (vs SPY)+48.54%
RS 6m (vs SPY)+200.40%
RS line new highNo
Trend template8/8
Technical rank96.2
1 week+10.98%
1 month+21.21%
3 months+62.87%
6 months+218.31%
1 year+669.57%
YTD+272.13%
P/E-66.06
P/B6.25
P/S
P/FCF-78.78
EPS-3.87
Div yield
ROE-9.46%
ROA-9.25%
Debt/Eq
Current38.51
EV/EBITDA-54.88
Gross margin
Net margin
Rev growth
EPS growth-25.93%
Price target147.63
Target upside40.33%
Analyst ratingBuy
Institutional98.84%
Ent. value6.7B
Revenue0
Net income-41.21M
Gross profit
Free cash flow-88.42M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.31M
Employees68
ListedTue, Sep 3, 2024
Free float35.3M
Float %72.9%
Short interest8.83M
Days to cover6.2d
Short volume71.1%
Squeeze score92 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.48 vs −$0.52
Last surprise+7.7% beat
Setup gradeA+
Conviction90 / 100
Pattern quality
Tech rank96.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance98.39
Support73.70
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ORKA

All disclosures →
No recent disclosed trades by Congress in ORKA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ORKA · 4 buys · 6 sells

InsiderSideShares
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Exercise3.5K
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Exercise3.5K
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Sell400
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Sell2.5K
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Sell3.8K
Goncalves Joana
Chief Medical Officer · Common Stock · 2026-07-15
Sell300
Goncalves Joana
Chief Medical Officer · Employee Stock Option (right to buy) · 2026-07-15
Exercise3.5K
Goncalves Joana
Chief Medical Officer · Employee Warrant (right to buy) · 2026-07-15
Exercise3.5K
Agarwal Arjun
Senior Vice President, Finance · Common Stock · 2026-07-13
Exercise8.54K
Agarwal Arjun
Senior Vice President, Finance · Common Stock · 2026-07-13
Exercise1.46K

SEC filings

EDGAR filings in ORKA · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.